Kinetic Studies of Ca2+ Release from Sarcoplasmic Reticulum of Normal and Malignant Hyperthermia Susceptible Pig Muscles
Overview
Biophysics
Authors
Affiliations
The time-course of Ca2+ release from sarcoplasmic reticulum isolated from muscles of normal pigs and those of pigs susceptible to malignant hyperthermia were investigated using stopped-flow spectrophotometry and arsenazo III as a Ca2+ indicator. Several methods were used to trigger Ca2+ release: (a) addition of halothane (e.g., 0.2 mM); (b) an increase of extravesicular Ca2+ concentration ([Ca2+0]); (c) a combination of (a) and (b), and (d) replacement of ions (potassium gluconate with choline chloride) to produce membrane depolarization. The initial rates of Ca2+ release induced by either halothane or Ca2+ alone, or both, are at least 70% higher in malignant hyperthermic sarcoplasmic reticulum than in normal. The amount of Ca2+ released by halothane at low [Ca2+0] in malignant hyperthermic sarcoplasmic reticulum is about twice as large as in normal sarcoplasmic reticulum. Membrane depolarization led to biphasic Ca2+ release in both malignant hyperthermic and normal sarcoplasmic reticulum, the rate constant of the rapid phase of Ca2+ release induced by membrane depolarization being significantly higher in malignant hyperthermic sarcoplasmic reticulum (k = 83 s-1) than in normal (k = 37 s-1). Thus, all types of Ca2+ release investigated (a, b, c and d) have higher rates in malignant hyperthermic sarcoplasmic reticulum than normal sarcoplasmic reticulum. These results suggest that the putative Ca2+ release channels located in the sarcoplasmic reticulum are altered in malignant hyperthermic sarcoplasmic reticulum.
King D, Hardin K, Hoeker G, Poelzing S Am J Physiol Heart Circ Physiol. 2022; 323(3):H363-H377.
PMID: 35749719 PMC: 9359653. DOI: 10.1152/ajpheart.00164.2022.
Dulhunty A, Beard N, Pouliquin P, Kimura T J Muscle Res Cell Motil. 2006; 27(5-7):351-65.
PMID: 16909197 DOI: 10.1007/s10974-006-9086-1.
Maruyama K, Yamagiwa M, Nishimura K, Konishi K, Muneyuki M J Anesth. 1992; 6(4):496-9.
PMID: 15278526 DOI: 10.1007/s0054020060496.
Wakamatsu M, Yamamoto M, Kirino Y, Katoh H, Shimonaka H, Nozawa Y J Anesth. 1989; 3(1):1-9.
PMID: 15236048 DOI: 10.1007/s0054090030001.
Molecular basis of the high-affinity activation of type 1 ryanodine receptors by imperatoxin A.
Lee C, Lee E, Takeuchi K, Takahashi H, Shimada I, Sato K Biochem J. 2003; 377(Pt 2):385-94.
PMID: 14535845 PMC: 1223873. DOI: 10.1042/BJ20031192.